ITV Studios Ent becomes Lifted, Syco’s Lee McNicholas named creative director ITV Studios Entertainment has been rebranded to Lifted Entertainment, and alongside its new name comes a new executive with Lee McNicholas joining as creative director, north.
McNicholas (pictured) will work with Lifted’s . March 15, 2021
ITV Studios Entertainment has been rebranded to Lifted Entertainment, and alongside its new name comes a new executive with Lee McNicholas joining as creative director, north.
McNicholas (pictured) will work with Lifted’s executive team including Angela Jain, managing director; director of entertainment Richard Cowles; creative directors Tom Gould and Fiona Clark; and Kat Hebden, head of development.
Published: Mar 15, 2021
March 15, 2021 10:00 UTC
Patients with a self-administered nasal spray application found to have reduced SARS-CoV-2 log viral load by more than 95% in infected participants within 24 hours of treatment, and by more than 99% in 72 hours
Trial concluded that treatment accelerated clearance of SARS-CoV-2 by a factor of 16-fold versus a placebo
Randomized, double-blind, placebo-controlled trial evaluated 79 confirmed cases of COVID-19, the majority heavily-infected with the UK variant
No adverse events were recorded in the group
Submission for Emergency Use in the UK and Canada for the treatment and prevention of COVID-19 is planned immediately
VANCOUVER, British Columbia & SURREY, England (BUSINESS WIRE) Biotech company
13 Ways to Maintain Brand Relevance Amidst Changing Industry Trends
Your industry is constantly changing. Learn how to change your brand along with it.
Newsweek Expert Forum members share industry insights.
Photos courtesy of the individual members
An industry never remains the same for too long. There will always be new trends or developments on the horizon, and if a brand doesn t evolve, it will soon be forgotten.
However, there are ways to keep your brand top of mind for consumers and industry peers. The key is being able to adapt and adjust your strategy to suit the times.
To help you do this, a panel of Newsweek Expert Forum members shared ways institutions can maintain relevance amidst the constant shifting trends and challenges in their industry.
Published: Mar 15, 2021 By Alex Keown
Smith Collection/Gado/Getty Images & Justin Sullivan/Getty Images
Two of the biggest drugmakers in the HIV space are
teaming up on a combination therapy that has the potential to be a game-changer for patients diagnosed with the dangerous virus for which there is no known cure.
This morning,
Gilead announced they would pair Gilead’s investigational capsid inhibitor, lenacapavir, and Merck’s investigational nucleoside reverse transcriptase translocation inhibitor, islatravir, into a two-drug regimen. Islatravir and lenacapavir are both potentially first-in-class medicines in late-stage clinical trials, with significant clinical data generated to date. Both medicines have long half-lives and have demonstrated activity at low dosages in clinical studies, which support development as an investigational combination regimen with long-acting formulations, both oral and injectable, the companies announced this morning. The combi
Xadago® in the rest of the world.
References:
Movement disorders : official journal of the Movement Disorder Society vol. 29 (10) p. 1273-80.
Anand R: Safinamide is associated with clinically important improvement in motor symptoms in fluctuating PD patients as add-on to levodopa (SETTLE). 17th International Congress of Parkinson’s Disease and Movement Disorders, Sydney, Australia, June 16-20, 2013.
About Parkinson’s disease and Levodopa (L-dopa) Induced Dyskinesia (LID)
PD is the second most common chronic progressive neurodegenerative disorder in the elderly after Alzheimer’s disease, affecting 1-2% of individuals aged ≥ 65 years worldwide. The prevalence of the PD market is expected to grow in the next years due to the increase in the global population and advancements in healthcare that contribute to an aging population at increased risk for PD. The diagnosis of PD is mainly based on observational criteria of muscular rigidity, resting tremor, or postural instabil